MedPath

A clinical study to evaluate the efficacy of oral administration of Nimbashatka choorna and Nimba malahara lepa with Vidangadi choorna and Nimba malahara lepa in itching per vagina.

Phase 2
Conditions
Health Condition 1: L292- Pruritus vulvae
Registration Number
CTRI/2024/07/071006
Lead Sponsor
Dr Gopika P
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Subjects irrespective of marital status

2) Subjects in perimenopausal and post-menopausal age group

3)Subjects diagnosed with classical symptoms of Acharana yonivyapath

4)Subjects with classical symptoms of Pruritus vulvae.

5)Subjects willing to sign the consent form

Exclusion Criteria

1.Subjects who are pregnant and lactating mothers.

2.Subjects during the time of menstruation.

3.Subjects with uncontrolled diabetes mellitus.

4.Subject with known case of sexually transmitted diseases.

5.Subject with known case of benign and malignant conditions.

6.Subject with known case of systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There is significant decrease in Pruritus vulvae which will be assessed based on 5-D Pruritus scaleTimepoint: Pre assessment 0th day <br/ ><br>1st assessment On 7th day <br/ ><br>Follow up On 15th day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Generation of in-depth analysis of duration, degree, direction, disability & distribution of Pruritus vulvae <br/ ><br>Generation of data on possible unexpected drug reaction. <br/ ><br>Timepoint: 0th day to 15th day <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath